Outset Medical, Inc.

For the period ended Sep 30, 2025. Filed Nov 10, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 10, 2025

OM$4.23+3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(in thousands, except per share amounts)

Three Months Ended · Nine Months Ended
	September 30,		September 30,
	2025	2024	2025	2024
Revenue:
Product revenue	$20,558	$20,305	$64,934	$59,971
Service and other revenue	8,873	8,361	25,668	24,251
Total revenue	29,431	28,666	90,602	84,222
Cost of revenue:
Cost of product revenue	11,169	11,532	33,962	34,680
Cost of service and other revenue	6,672	7,314	22,117	21,725
Total cost of revenue	17,841	18,846	56,079	56,405
Gross profit	11,590	9,820	34,523	27,817
Operating expenses:
Research and development	5,376	8,139	16,180	30,508
Sales and marketing	13,550	15,417	41,482	54,593
General and administrative	8,477	10,103	25,938	34,231
Total operating expenses	27,403	33,659	83,600	119,332
Loss from operations	(15,813)	(23,839)	(49,077)	(91,515)
Interest income and other income, net	1,855	2,149	5,734	7,718
Interest expense	(3,476)	(6,068)	(10,511)	(18,046)
Loss on extinguishment of term loan	—	—	(7,685)	—
Loss before provision for income taxes	(17,434)	(27,758)	(61,539)	(101,843)
Provision for income taxes	404	182	623	495
Net loss	$(17,838)	$(27,940)	$(62,162)	$(102,338)
Net loss per share, basic and diluted	$(1.00)	$(8.02)	$(4.37)	$(29.71)
Shares used in computing net loss per share, basic and diluted	17,783	3,484	14,228	3,445

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.